Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer

Cytokine

Volumn 77, Issue , 2016, Pages 50-55

  Shen, Xu Dong ^a   Zhang, Li ^a   Che, Hong ^a   Zhang, Yang Yang ^a   Yang, Cheng ^a   Zhou, Jun ^a   Liang, Chao Zhao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Adipokine; Obesity; Omentin 1; Renal cell cancer

Indexed keywords

ADIPOCYTOKINE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; CARCINOMA, RENAL CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; KIDNEY NEOPLASMS; MIDDLE AGED; STATISTICAL MODEL;

ADIPOKINES; BODY MASS INDEX; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GPI-LINKED PROTEINS; HUMANS; KIDNEY NEOPLASMS; LECTINS; LOGISTIC MODELS; MALE; MIDDLE AGED; WAIST-HIP RATIO;

EID: 84946234406     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.09.004     Document Type: Article

References (44)

1. Liu Q., Rexiati M., Yang Y., Wang W.G., Azhati B., Saimaiti W., et al. Expression of chemokine receptor 4 was associated with poor survival in renal cell carcinoma. Med. Oncol. 2014, 31:882.
2. Siegal R., Ma J., Zou Z., Jemal A. Cancer statistics 2014. CA Cancer J. Clin. 2014, 64(1):9-29.
3. Chow W.H., Dong L.M., Devesa S.S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 2010, 7(5):245-257.
4. Ljungberg B., Campbell S.C., Choi H.Y., Jacqmin D., Lee J.E., Weikert S., et al. The epidemiology of renal cell carcinoma. Eur. Urol. 2011, 60(4):615-621.
5. Lowrance W.T., Thompson R.H., Yee D.S., Kaag M., Donat S.M., Russo P. Obesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologies. BJU Int. 2010, 105(1):16-20.
6. Mathew A., George P.S., Ildaphonse G. Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac. J. Cancer Prev. 2009, 10(2):279-286.
7. Wang F., Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int. J. Cancer. 2014, 135(7):1673-1686.
8. Renehan A.G., Tuson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371(9612):569-578.
9. De Pergola G., Silvestris F. Obesity as a major risk factor for cancer. J. Obes. 2013, 2013:291546.
10. Liao L.M., Schwartz K., Pollak M., Graubard B.I., Li Z., Ruterbusch J., et al. Serum leptin and adiponectin levels and risk of renal cell carcinoma. Obesity (Sliver Spring) 2013, 21(7):1478-1485.
11. Liao L.M., Weinstein S.J., Pollak M., Li Z., Virtamo J., Albanes D., et al. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers. Carcinogenesis 2013, 34(1):109-112.
12. Spyridopoulos T.N., Petridou E.T., Dessypris N., Terzidis A., Skalkidou A., Deliveliotis C., et al. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens) 2009, 8(1):39-46.
13. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am. J. Physiol. Endocrinol. Metab. 2006, 290(6):E1253-E1261.
14. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56(6):1655-1661.
15. Tekce H., Tekce B.K., Aktas G., Alcelik A., Sengul E. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease. Exp. Clin. Endocrinol. Diabetes 2014, 122(8):451-456.
16. Sengul E., Duygulu G., Dindar S., Bunul F. Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease. Ren. Fail. 2013, 35(8):1089-1093.
17. Fazeli M.S., Dashti H., Akbarzadeh S., Assadi M., Aminian A., Keramati M.R., et al. Circulating levels of novel adipocytokines in patients with colorectal cancer. Cytokine 2013, 62(1):81-85.
18. Uyeturk U., Sarici H., Kin Tekce B., Eroglu M., Kemahli E., Uyeturk U., et al. Serum omentin level in patients with prostate cancer. Med. Oncol. 2014, 31(4):923-926.
19. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150(9):604-612.
20. Gitaua T.M., Micklesfieldab L.K., Pettifora J.M., Norrisa S.A. Eating attitudes, body image satisfaction and self-esteem of South African Black and White male adolescents and their perception of female body silhouettes. J. Child. Adoles. Mental Heal. 2014, 26(3):193-205.
21. Tesfaye M., Hanlon C., Tessema F., Prince M., Alem A. Common mental disorder symptoms among patients with malaria attending primary care in ethiopia: a cross-sectional survey. PLoS One 2014, 9(9):e108923.
22. Wierzejska R., Jarosz M., Siuba M., Sawicki W. Comparison of maternal and fetal blood levels of caffeine and its metabolite: a pilot study. Ginekol. Pol. 2014, 85(7):500-503.
23. Chang L., Wu J., Cao L. Combination of symptoms and oxygen desaturation index in predicting childhood obstructive sleep apnea. Int. J. Pediatr. Otorhinolaryngol. 2013, 77(3):365-371.
24. Baars J.E., Vogelaar L., Wolfhagen F.H., Biermann K., Kuipers E.J., van der Woude C.J. A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. J. Crohns Colitis 2010, 4(6):661-668.
25. Vicedo E., Schlessinger A., Rost B. Environmental pressure may change the composition protein disorder in prokaryotes. PLoS One 2015, 10(8):e0133990.
26. Choi Y., Park B., Jeong B.C., Seo S.I., Jeon S.S., Choi H.Y., et al. Body mass index and survival in patients with renal cell carcinoma: a clinical-based cohort and meta-analysis. Int. J. Cancer 2013, 132(3):625-634.
27. Komura K., Inamoto T., Black P.C., Koyama K., Katsuoka Y., Watsuji T., et al. Prognostic significance of body mass index in Asian patients with localized renal cell carcinoma. Nutr. Cancer 2011, 63(6):908-915.
28. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295(13):1549-1555.
29. Bergström A., Hsieh C.C., Lindblad P., Lu C.-M., Cook N.R., Wolk A. Obesity and renal cell cancer-a quantitative review. Br. J. Cancer 2001, 85(7):984-990.
30. Ohno Y., Nakashima J., Nakagami Y., Satake N., Gondo T., Ohori M., et al. Sex and the clinical value of body mass index in patients with clear cell renal cell carcinoma. Br. J. Cancer 2013, 109(7):1899-1903.
31. Hakimi A.A., Furberg H., Zabor E.C., Jacobsen A., Schultz N., Ciriello G., et al. An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma. J. Natl. Cancer Inst. 2013, 105(24):1862-1870.
32. Cho H.J., Kim S.J., Ha U.S., Hong S.H., Kim J.C., Choi Y.J., et al. Prognostic value of capsular invasion for localized clear-cell renal cell carcinoma. Eur. Urol. 2009, 56(6):1006-1012.
33. Jeon H.G., Jeong I.G., Lee J.H., Lee C.J., Kwak C., Kim H.H., et al. Prognostic value of body mass index in Korean patients with renal cell carcinoma. Nutr. Cancer 2011, 63(6):908-915.
34. Smits K.M., Schouten L.J., Hudak E., Verhage B., van Dijk B.A., Hulsbergen-van de Kaa C.A. Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: results of the Netherlands Cohort Study on diet and cancer. Ann. Epidemiol. 2010, 20(5):401-404.
35. Stattin P., Soderberg S., Hallmans G., Bylund A., Kaaks R., Stenman U.H., et al. Leptin is associated with increased prostate cancer risk: a nested case-referent study. J. Clin. Endocrinol. Metab. 2001, 86(3):1341-1345.
36. Choi J.H., Rhee E.J., Kim K.H., Woo H.Y., Lee W.Y., Sung K.C. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome. Eur. J. Endocrinol. 2011, 165(5):789-796.
37. Tan B.K., Adya R., Farhatullah S., Lewandowski K.C., O'Hare P., Lehnert H., et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome. Diabetes 2008, 57(4):801-808.
38. Zhang Y.Y., Zhou L.M. Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. Eur. J. Pharmacol. 2013, 698(1-3):137-144.
39. Mogal A.P., van der Meer R., Crooke P.S., Abdulkadir S.A. Haploinsufficient prostate tumor suppression by Nkx3.1: a role for chromatin accessibility in dosage-sensitive gene regulation. J. Biol. Chem. 2007, 282(35):25790-25800.
40. Kataoka Y., Shibata R., Ohashi K., Kambara T., Enomoto T., Uemura Y., et al. Omentin prevents myocardial ischemic injury through AMP-activated protein kinase- and Akt-dependent mechanisms. J. Am. Coll. Cardiol. 2014, 63(24):2722-2733.
41. Lim K.H., Ancrile B.B., Kashatus D.F., Counter C.M. Tumour maintenance is mediated by eNOS. Nature 2008, 452(7187):646-649.
42. Wada J. Vaspin: a novel serpin with insulin-sensitizing effects. Expert Opin. Inv. Drug. 2008, 17(3):327-333.
43. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., et al. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 2005, 11(11):1188-1196.
44. Cancer Genome Atlas Research Network Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013, 499(7456):43-49.